COSYNE Trademark

Trademark Overview

On Friday, May 20, 2022, a trademark application was filed for COSYNE with the United States Patent and Trademark Office. The USPTO has given the COSYNE trademark a serial number of 97420492. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Thursday, August 28, 2025. This trademark is owned by CoSyne Therapeutics Limited. The COSYNE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals, namely, neurological and oncological pharmaceutical products; pharmaceuticals, namely, neurological and oncological pharmaceutical preparations; pharmaceutical preparations for the treatment and prevention of neurological diseases and cancer; pharmaceutical products for the treatment and prevention of neurological diseases and cancer
cosyne

General Information

Serial Number97420492
Word MarkCOSYNE
Filing DateFriday, May 20, 2022
Status733 - FOURTH EXTENSION - GRANTED
Status DateThursday, August 28, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 9, 2023

Trademark Statements

Goods and ServicesPharmaceuticals, namely, neurological and oncological pharmaceutical products; pharmaceuticals, namely, neurological and oncological pharmaceutical preparations; pharmaceutical preparations for the treatment and prevention of neurological diseases and cancer; pharmaceutical products for the treatment and prevention of neurological diseases and cancer
Pseudo MarkCOSINE

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, May 25, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCoSyne Therapeutics Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressLondon WIF8BH
GB
Party NameCoSyne Therapeutics Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLondon WIF8BH
GB

Trademark Events

Event DateEvent Description
Friday, March 10, 2023NON-FINAL ACTION WRITTEN
Tuesday, May 24, 2022NEW APPLICATION ENTERED
Wednesday, May 25, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, March 9, 2023ASSIGNED TO EXAMINER
Friday, March 10, 2023NON-FINAL ACTION E-MAILED
Friday, March 10, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, March 29, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, March 29, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, March 30, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, March 31, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, May 9, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Monday, August 21, 2023DIVISIONAL REQUEST RECEIVED
Wednesday, April 19, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 9, 2023PUBLISHED FOR OPPOSITION
Tuesday, July 4, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Saturday, August 26, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, September 19, 2023DIVISIONAL PROCESSING COMPLETE
Monday, August 21, 2023TEAS REQUEST TO DIVIDE RECEIVED
Wednesday, January 3, 2024SOU EXTENSION 1 FILED
Wednesday, September 20, 2023CORRECTED NOA E-MAILED
Wednesday, January 3, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, January 3, 2024SOU EXTENSION 1 GRANTED
Thursday, July 4, 2024SOU TEAS EXTENSION RECEIVED
Thursday, July 4, 2024SOU EXTENSION 2 GRANTED
Thursday, July 4, 2024SOU EXTENSION 2 FILED
Monday, January 6, 2025SOU EXTENSION 3 FILED
Wednesday, July 2, 2025TEAS PETITION TO REVIVE RECEIVED
Wednesday, July 2, 2025PETITION TO REVIVE-GRANTED
Wednesday, July 2, 2025SOU EXTENSION RECEIVED WITH TEAS PETITION
Sunday, July 6, 2025SOU EXTENSION 4 FILED
Monday, July 28, 2025ASSIGNED TO PETITION STAFF
Thursday, July 31, 2025INCOMPLETE PETITION NOTICE MAILED
Thursday, August 21, 2025TEAS RESPONSE TO PETITION DEFICIENCY RECEIVED
Thursday, August 28, 2025PETITION GRANTED - EXTENSION REQUEST FILED
Friday, January 5, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 4, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 2, 2025NOTICE OF REVIVAL - E-MAILED
Wednesday, July 2, 2025PETITION TO REVIVE-RECEIVED
Friday, July 18, 2025TEAS RESPONSE TO PETITION DEFICIENCY RECEIVED
Thursday, August 28, 2025NOTICE OF REVIVAL - E-MAILED
Thursday, August 28, 2025SOU EXTENSION 3 GRANTED
Monday, September 15, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 15, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 28, 2025SOU EXTENSION 4 GRANTED

Related Keywords

cosyne pharmaceutical neurological prevention cancer diseases treatment products namely oncological pharmaceuticals